PT - JOURNAL ARTICLE AU - Yong-Wei Fu AU - Hong-Zhi Xu TI - Expression of deubiquitinases in human gingiva and cultured human gingival fibroblasts AID - 10.1101/2021.01.26.21250532 DP - 2021 Jan 01 TA - medRxiv PG - 2021.01.26.21250532 4099 - http://medrxiv.org/content/early/2021/03/16/2021.01.26.21250532.short 4100 - http://medrxiv.org/content/early/2021/03/16/2021.01.26.21250532.full AB - Background Although deubiquitinating enzymes (DUBs) such as CYLD, A20 and OTULIN are expressed in multiple tissues and thought to be linked with inflammatory diseases, their expression in periodontal tissues remains to be determined. This research was designed to assess the expression of CYLD, A20 and OTULIN in human gingiva, and to evaluate the regulation of these DUBs in human gingival fibroblasts (HGFs) upon different stimuli.Methods Immunohistochemistry assay was conducted to determine the expression of CYLD, A20 and OTULIN in human gingiva. Immunofluorescence assay was employed to observe the protein expression of CYLD, A20 and OTULIN in HGFs. RT-PCR and western blots were carried out to assess gene and protein expression changes of these DUBs in HGFs upon LPS or TNF-α.Results CYLD, A20 and OTULIN were found to be expressed in human gingiva and HGFs. Further, the expression of CYLD, A20 and OTULIN in HGFs exhibited distinct regulation by different stimuli.Conclusions Our findings suggest that CYLD, A20 and OTULIN might play a role in the progression of periodontitis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by Lianyungang Health Development Project with Science and Education (2017-26).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by The Ethics Committee of Nanjing Medical University (2018389)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data set supporting the results of this article are available from the corresponding author.DUBsDeubiquitinating enzymesHGFsHuman gingival fibroblastsPBSPhosphate buffered salineRT-PCRReverse transcription polymerase chain reaction